Sulforaphane activates Nrf2 (nuclear factor erythroid 2-related factor 2) by modifying Keap1, the protein that normally keeps Nrf2 locked in the cytoplasm. When sulforaphane modifies Keap1, Nrf2 is released, enters the nucleus, and switches on over 200 cytoprotective genes including: glutathione S-transferases (phase II detox), NAD(P)H quinone oxidoreductase (NQO1), heme oxygenase-1 (anti-inflammatory), and glutathione synthesis enzymes. This massive upregulation of cellular defenses is why sulforaphane shows benefits across such diverse conditions, it's not treating a specific disease, it's enhancing the body's fundamental protection systems.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.